These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11877762)

  • 1. The combination of external beam radiotherapy and experimental radioimmunotargeting with a monoclonal anticytokeratin antibody.
    Johansson A; Eriksson D; Ullén A; Löfroth PO; Johansson L; Riklund-Ahlström K; Stigbrand T
    Cancer; 2002 Feb; 94(4 Suppl):1314-9. PubMed ID: 11877762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental radioimmunotargeting combining nonlabeled, iodine-125-labeled, and anti-idiotypic anticytokeratin monoclonal antibodies: a dosimetric evaluation.
    Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
    Cancer; 1997 Dec; 80(12 Suppl):2689-98. PubMed ID: 9406726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies.
    Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
    Cancer; 1997 Dec; 80(12 Suppl):2681-8. PubMed ID: 9406725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry of fractionated administration of 125I-labeled antibody at experimental radioimmunotargeting.
    Ullén A; Sandström P; Rossi Norrlund R; Rathsman S; Johansson L; Riklund Ahlström K; Hietala SO; Stigbrand T
    Cancer; 1997 Dec; 80(12 Suppl):2510-8. PubMed ID: 9406704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours.
    Eriksson D; Joniani HM; Sheikholvaezin A; Löfroth PO; Johansson L; Riklund Ahlström K; Stigbrand T
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):895-906. PubMed ID: 12721768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and immunoreactivity of the monoclonal anticytokeratin antibody TS1 after different degrees of iodination.
    Johansson A; Sandström P; Ullén A; Erlandsson A; Sundström B; Ahlström KR; Johansson L; Hietala SO; Stigbrand T
    Acta Oncol; 1999; 38(3):329-34. PubMed ID: 10380824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S; Trisler K; Wessels BW; Knox SJ
    Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalization.
    Ullén A; Sandström P; Ahlström KR; Sundström B; Nilsson B; Arlestig L; Stigbrand T
    Cancer Res; 1995 Dec; 55(23 Suppl):5868s-5873s. PubMed ID: 7493362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of systemic radiotherapy with I-131-labeled monoclonal antibody BW575/9 to external beam radiotherapy in human neuroblastoma xenografts.
    Sautter-Bihl ML; Wessely R; Bihl H
    Strahlenther Onkol; 1993 Oct; 169(10):595-600. PubMed ID: 8235984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.
    Kelly MP; Lee FT; Smyth FE; Brechbiel MW; Scott AM
    J Nucl Med; 2006 Apr; 47(4):716-25. PubMed ID: 16595507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined modality radioimmunotherapy. Promise and peril.
    Burke PA; DeNardo SJ; Miers LA; Kukis DL; DeNardo GL
    Cancer; 2002 Feb; 94(4 Suppl):1320-31. PubMed ID: 11877763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of growth of HeLa cell tumours in nude mice by 125I-labeled anticytokeratin and antiPLAP monoclonal antibodies.
    Riklund KE; Makiya R; Sundström B; Bäck O; Henriksson R; Hietala SO; Stigbrand T
    Anticancer Res; 1991; 11(2):555-60. PubMed ID: 1712175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinations of nonlabeled, 125I-labeled, and anti-idiotypic antiplacental alkaline phosphatase monoclonal antibodies at experimental radioimmunotargeting.
    Rossi Norrlund R; Holback D; Johansson L; Hietala SO; Ahlström KR
    Acta Radiol; 1997 Nov; 38(6):1087-93. PubMed ID: 9394676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9.
    Modak S; Guo HF; Humm JL; Smith-Jones PM; Larson SM; Cheung NK
    Cancer Biother Radiopharm; 2005 Oct; 20(5):534-46. PubMed ID: 16248769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
    Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
    J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous anti-tumor antibody responses in nude mice.
    Stigbrand T; Ullén A; Sandström P; Rathsman S; Rossi Norrlund R; Arlestig L; Riklund Ahlström K; Hietala SO
    Cancer; 1997 Dec; 80(12 Suppl):2404-10. PubMed ID: 9406690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of complexed anticytokeratin 8 scFv TS1-218 to HeLa HEp-2 multicellular tumor spheroids and experimental tumors.
    Jafari R; Holm P; Sandegren J; Stigbrand T; Sundström BE
    Cancer Biother Radiopharm; 2010 Aug; 25(4):455-63. PubMed ID: 20707717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.